STOCKHOLM--(BUSINESS WIRE)--Elekta AB (publ) (STO:EKTAB) today announced it has successfully completed its acquisition of Nucletron, the world leader in brachytherapy treatment planning and delivery. Through the combination Elekta will offer a complete range of radiotherapy planning and delivery technologies. As the market leader in Europe and with strong positions in North America and Asia, Elekta will enhance the combined ability to meet the clinical needs of cancer patients and health care providers throughout the world.
